BUSINESS AREA - ONCOLOGY BUSINESS UNIT (OBU)

We're all here to make an impact - to achieve our bold ambition of eliminating cancer as a cause of death.

In the Oncology Business Unit we relentlessly follow the science, challenging the status quo to deliver more effective treatments to patients in need. Our commitment means we purposefully push back the limits of knowledge to change the practice of medicine. To ensure no patient is left behind, no matter what stage of disease.

Fast-paced and ever-changing, it takes agility and responsiveness to stay committed in our pursuit of excellence. We work with focus and a sense of urgency to tackle the unanswered questions - innovating, challenging accepted norms, quick decision-making and taking smart risks. A place of trust, it's an opportunity to take accountability, be brave, speak up, step up and disrupt to change the game for Oncology, now and in the future.

What you'll do - Senior Director, Global Analytics and Insights (GA&I):

The Global Analytics & Insights mission is to improve the quality of the decisions taken on our assets and across our Disease Areas through the provision of excellent market, customer and competitor analytics. This role will focus on specific assets and/or tumor indications and lead a programme of insight and analysis to support clinical development through commercialization. In addition, you will act as a thought partner to the Global Franchise Head to provide deep insights and strategic direction in supportive of franchise level initiatives.

Responsibilities:

• Portfolio wide above indication analysis and strategic projects
  
  • Act as point of contact for the specific tumor indication portfolio and the Brand in the Global Oncology franchise to engage in global brand strategy development and business planning, in collaboration with cross functional leads at global level and key markets
  • Build institutional knowledge of key disease areas in the tumor indication space, including HCP and patient insights, market dynamics, competitive landscape and key implication on AZ portfolio
  • Execute key strategic projects for disease area portfolio and the Brand in partnership with the Franchise leadership and functions
  • Serve as knowledge expert to take lead role in planning and expanding capabilities to support CDP and commercial strategy planning of future new assets within the Franchise

• GA&I lead for specific tumour indications
  
  • Develops a deep therapy area knowledge bridging from the clinical development through to commercialization
  • Uncovers deep strategic understanding of patients, markets, stakeholders, competitors, and brands to drive competitive advantage now and for the future
  • Is a collaborative and strategic partner to both the Global Brand Team and R&D Product teams bringing objectivity to inform better decision making
  • Provides an independent view in decision-making bodies with an external perspective, and a future-oriented focus
  • Leads the integration of insight and analysis from a variety of sources to inform material decisions through the delivery of robust opportunity focused forecasts. Consolidates a variety of data and information into actionable brand opportunities
  • Provides objective quantitative analyses and leads the development of business cases to determine key opportunities and address critical business issues for the brand and/or TA

• Lead a small team of Global Analytics and Insights experts
  
  • Build an inclusive, high-performing, and collaborative team

Essential Requirements:

• Advanced degree in a Science or Mathematics Discipline and/or MBA
• 6+ years of analytical experience in the pharmaceutical/consulting industry
• Excellent communication skills
• Experience with senior executive engagement and communication
• Experience in a similar strategy role within the pharmaceutical industry or life science consulting
• Ability to use data and analysis to affect, influence or change the understanding of a market or customer

Desirable Requirements:

• Experience in a consulting, advisory or investment firm working within the pharmaceutical industry
• Experience of working with a pharma product close to launch or post-launch
• Experience of working in a global team

The annual base pay for this position ranges from $218,329.60 - $327,494.40. Hourly and salaried non-exempt employees will also be paid overtime pay when working qualifying overtime hours. Base pay offered may vary depending on multiple individualized factors, including market location, job-related knowledge, skills, and experience. In addition, our positions offer a short-term incentive bonus opportunity; eligibility to participate in our equity-based long-term incentive program (salaried roles), to receive a retirement contribution (hourly roles), and commission payment eligibility (sales roles). Benefits offered included a qualified retirement program [401(k) plan]; paid vacation and holidays; paid leaves; and, health benefits including medical, prescription drug, dental, and vision coverage in accordance with the terms and conditions of the applicable plans. Additional details of participation in these benefit plans will be provided if an employee receives an offer of employment. If hired, employee will be in an "at-will position" and the Company reserves the right to modify base pay (as well as any other discretionary payment or compensation program) at any time, including for reasons related to individual performance, Company or individual department/team performance, and market factors.

Date Posted
07-Aug-2026

Closing Date
21-Aug-2026